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Abstract—The MobiGuide system provides patients with 
personalized decision support tools, based on computerized 
clinical guidelines, in a mobile environment. The generic capa-
bilities of the system will be demonstrated applied to the clini-
cal domain of Gestational Diabetes (GD). This paper presents 
a methodology to identify personalized recommendations, 
obtained from the analysis of the GD guideline. We added a 
conceptual parallel part to the formalization of the GD 
guideline called "parallel workflow" that allows considering 
patient's personal context and preferences. As a result of ana-
lysing the GD guideline and eliciting medical knowledge, we 
identified three different types of personalized advices (ther-
apy, measurements and upcoming events) that will be imple-
mented to perform patients' guiding at home, supported by the 
MobiGuide system. These results will be essential to determine 
the distribution of functionalities between mobile and server 
decision support capabilities. 
Keywords—m-health, clinical guidelines, personalized care, 
decision support system. 
I. INTRODUCTION 
Clinical Practical Guidelines (CPGs) collect recommenda-
tions on the appropriate treatment and care of people with a 
specific disease and conditions, and they are based on a sys-
tematic review of clinical evidence. Care providers can use 
CPGs for treatment, but time constraints hamper the access to 
the knowledge accumulated during patient encounters. 
Computer-interpretable Guidelines (CIGs) are usually de-
veloped based on the text of CPGs [1]. They can be used to 
support clinicians' decision making processes, by automati-
cally generating recommendations about what medical pro-
cedures to perform tailored for each individual patient [2]. 
A significant amount of knowledge is still left as implicit 
in CPGs and should be turned into explicit knowledge dur-
ing the Knowledge Acquisition (KA) process. Some of the 
implicit knowledge is specific to the local implementing 
institution, and includes organizational workflow and 
constraints, goals, and scope. The KA process is usually 
performed by knowledge engineers (KEs) in collaboration 
with Expert Physicians (EPs) from the institution at which 
the CIG is to be implemented. 
It is difficult to tailor care workflows to the needs of the 
individual patient. Implementing CPGs in a decision sup-
port system with an interface to an electronic health record 
(EHR) makes the application of guidelines more personal 
and more likely to be accepted during clinical care [3]. 
The EU FP7 funded project MobiGuide (MG) [4] pro-
vides patient guidance services based on CIGs supported by 
an intelligent decision-support system. The system helps 
patients manage their illness by monitoring disease parame-
ters and providing the appropriate feedback personalized to 
patients' preferences and context in a mobile environment. 
The system is based on the best available clinical evidence 
personalized to the patient's personal circumstances and 
technological context. 
The main components of the MG System are: 1) A back-
end Decision Support System (DSS) devoted to the repre-
sentation and execution of CIGs, which is complemented by 
a mobile DSS that supports the distribution of guideline 
parts; 2) A Body Area Network (BAN) that provides real-
time monitoring of biosignals and communicates with the 
backend server and; 3) A Personal Health Record (PHR) 
that is ubiquitously and securely accessible and collects 
patients' personal and monitoring data. The MG system and 
its clinical effectiveness will be evaluated in patients with 
Gestational Diabetes (GD) as one of the application areas. 
This paper presents a methodology to identify persona-
lized patient recommendations obtained from the analysis of 
a specific CPG. The GD local guideline has been elicited to 
formalize the knowledge representation and to allow creat-
ing the ontology specific consensus [5], which describes 
schematically the interpretation of the GL agreed by both 
the EPs and the KEs. In this work, we added a conceptual 
parallel part to the process of formalization that focuses on 
patient behaviour, called "parallel workflow". The aim was 
to consider patient context and patient preferences so that 
we can generate recommendations, warnings or reminders 
able to guide patients at home supported by the MG system. 
II. MATERIALS AND METHODS 
In order to elicit the Gestational Diabetes CPG, we 
implemented the KA methodology that was previously 
developed and evaluated for the specification of CPGs by 
EPsandKEs[5, 6]. 
This methodology starts with choosing the specification 
language and continues with instructing the EPs about the 
KA process. Then, the appropriate CPGs for formalization 
are selected. The EPs of 'Hospital de Sabadell' created the 
local GD CPG implementation [7]. The process continues 
with making an ontology specific consensus. This phase is 
important because although CPGs are evidence based, some 
actions do not appear in the CPG but are still considered 
correct by some physicians, and because not all physicians 
will necessarily consider everything in the CPG as relevant 
and applicable to the patient. We focused on creating the 
local consensus and elaborated it with patient-
customization, personalization and technological-context 
aspects. We used a CPG graphical representation iteratively 
to produce this local consensus. 
In order to extract patient-tailored parallel workflows 
from the CPG, we identified those recommendations that 
might imply an advice for the patient, typically to be carried 
out at home (e.g. to measure blood glucose (BG)). Recom-
mendations that imply advice for the patient are also the 
starting point of a process of care (workflow) that is parallel 
to the CPG and completely patient-centric. The result of the 
process is a customized CIG including the recommenda-
tions for care professionals and the corresponding recom-
mendations to be addressed to patients (see Figure 1). 
Figure 2 shows an example of the parallel workflow 
applied to GD monitoring plan. In "traditional" CIGs, 
recommendations 1-5 are directed toward the care profes-
sionals, and the care professionals explain them to their 
patients, but they are not actually applied in a functional 
automatic manner by a DSS. For example, after enhancing 
the plan for BG monitoring with a parallel workflow, it now 
contains recommendations for the patient and can be further 
Fig. 1 Methodology for GL formalization and patient-tailored workflow 
patterns identification that produces a customized CIG 
Care professional "traditional" plan Patient "parallel workflow" plan 
Fig. 2 An example of parallel workflow for BG monitoring 
decomposed into a formal monitoring plan which can be 
executed by the patient's mobile (Smartphone). 
III. RESULTS 
The analysis of the GD guideline, done by KEs in 
consultation with EPs of 'Hospital de Sabadell', took a total 
time duration of 4 months along 10 iterations. It led to the 
extraction of a set of workflow patterns, related to three 
types of advices: 
A. Therapy Advisors, to Help the Patient to Comply with 
Her Treatment 
Patients with GD are responsible for following therapy 
prescriptions at home. Therapy prescription in GD is mainly 
related to three types of recommendations: a) Nutritional 
therapy; b) Exercise; and c) Insulin therapy. 
For some women, showing a good compliance to nutri-
tional and exercise recommendations can avoid to adminis-
ter insulin. Due to this reason, mechanisms to reinforce the 
patient's compliance to diet and physical activity could 
contribute significantly to keep a good metabolic control. 
Patients with GD are trained to estimate the amount of car-
bohydrates for each meal so that they can follow nutritional 
prescription correctly. Also they are instructed to write 
down in their personal's logbook whether they are not fol-
lowing nutritional prescription or eating forbidden nutrients 
and the motivation for not following recommendations. 
Clinicians check the patient's compliance to diet and ex-
ercise during clinical encounters, where they can assess the 
importance of not following compliance. MG will detect 
possible situations of non-compliance related to diet and 
physical activity, and ask the patient for confirmation. 
In MG, physical activity practicing and its intensity is de-
tected automatically with a physical activity detector. In order 
to estimate compliance to diet, the system will need to trust the 
subjective estimation of carbohydrates for each meal intake. 
The parallel workflow pattern for diet and exercise com-
pliance can control the patient's adherence to recommenda-
tions. When not following recommendations repeatedly, the 
patient will receive an alert to show the importance of fol-
lowing compliance such as: (e.g. "Try to avoid food with 
high glucose content such as cakes " or "Try to increase the 
duration of physical activity to improve glycemic control"). 
Also, patients will receive feedback from the system when 
they follow recommendations, so that they can feel that 
their efforts while managing the disease are recognized. 
It is especially important to know if the patient is not 
following nutritional prescription when there are high BG 
levels, as BG measurements are associated to diet intakes 
along the day. Patients could receive specific recommenda-
tions when one of these situations is detected (e.g. "Your 
BG has been elevated associated to high glucose intake, you 
should follow the recommendations"). 
Depending on the side effect of non-compliance, related 
to exercise and/or diet prescription, the clinician in charge 
of the patient should be informed. 
As in the example in Table 1, patients will be asked spe-
cifically about non-compliance related to the presence of 
high BG levels. Additionally, the patient will be able to 
write down the reason why she is not following diet rec-
ommendations (as in first data entry). When the importance 
of non-compliance is medium or high and repeated in dif-
ferent days/meal-intervals (as in third and fourth data en-
tries), a clinical decision about therapy might be necessary. 
For patients that require insulin administration, insulin 
doses will be registered to assess compliance. The patient 
can receive specific reminders about when to administer 
insulin, following her personalized schedule of meals (con-
sidering working days and weekends). 
Insulin compliance needs to be monitored to determine 
the relationship cause-effect when analyzing BG levels. The 
system will ask the patient about insulin compliance, 
especially when anomalous BG levels are detected. 
Table 2 shows an example of non-compliance related to 
insulin administration. Patient P I presents hypoglycemia 
levels associated to the administration of an insulin dose 
Table 1 Example of non-compliance to nutritional therapy and high BG 
(* repeated anomalous BG due to non-compliance) 
Abs. 
Time 
Intake 
BG 
(mg/ 
dL) 
BG 
moment 
Diet Type 
of 
food 
Rea-
son 
Impor-
tance 
Cake Party 
Ice 
cream 
Low 
High 
16/03/201 125 Dinner Post- + 
3 22:30 prandial 
16/03/201 165 Lunch Post- ++ 
3 15:30 prandial 
17/03/201 148 Dinner Post- + - Birth- Medium* 
3 21:30 prandial day 
18/03/201 145 Dinner Post- ++ Dou- Skip High* 
3 21:30 prandial ble prev. 
carbs meal 
Table 2 Example related to non-compliance to insulin administration 
Abs. Time ID BG Intake BG Insulin Reason Importa 
value moment nee 
16/03/2013 P I 70 Lunch Postpran +1U Eat more Medium 
13:30 dial carbs. 
16/03/2013 P_2 165 Breakf Postpran -3 U Unknown High 
15:30 ast dial 
18/03/2013 P_2 148 Lunch Postpran 0U Forgot High 
14:13 dial 
18/03/2013 P I 65 Dinner Postpran +2 U Eat more High 
14:30 dial carbs. 
higher than recommended in two situations, so she would 
receive specific recommendations to reinforce the correct 
therapy use (e.g. "Administering more insulin than recom-
mended is producing hypoglycemia events"). Patient P_2, 
instead, seems to be skipping insulin doses and presents 
repeated hyperglycemia, so she will receive recommenda-
tions to reinforce the importance of following prescription. 
B. Measurements Advisors, to Remind the Patient to Take 
Specific Measurements 
GD management requires monitoring several variables 
daily and assessing the results periodically. Usually clini-
cians perform this process during encounters at the hospital, 
which happens every week or every two weeks. MG will 
monitor variables with specific sensors or manually in the 
Smartphone's logbook. For some patients, MG can be used 
to remind when each measurement should be performed. 
Only patients interested in this option will receive reminders 
about specific measurements such as BG or ketonuria. It is 
important to take into account that patients should not be 
overloaded with excessive reminders, as this might have the 
opposite result than expected. Patients could finish leaving 
pass messages if they are too demanding for them. Other 
parameters required to monitor compliance (diet, insulin or 
exercise) will not be part of this type of reminders. 
Also, non-compliance in the process of measurement will 
be considered for the main clinical parameters (BG, ketonu-
ria, blood pressure). When the patient does not perform 
measurements frequently enough or when she is not down-
loading data to the system so that data can be analyzed 
according to periodic requirements, the patient will be re-
minded. If the same situation is kept, the patient could be 
cited to attend an on-site visit, after warning the clinician. 
C. Upcoming Event Advisors, for Dealing with Personal 
Situations 
There are several significant personal events that can lead to 
delivery of GD guideline recommendations in the MobiGuide 
system. These can be related to situations where the diet, phys-
ical activity and schedule of the patient may not be routine, as 
in an upcoming holiday or party. Respective advisors could be 
addressed to the patients using the Smartphone interface, 
regarding changes to therapy and measurement schedule 
associated to different types of personalized events. 
We have identified several parameters to be personalized 
by each patient with GD, depending on the specific sche-
dule or the presence of special events (see the example in 
Table 3). When required, personalization parameters will be 
supervised by clinicians. 
For example, patients could personalize their preferred 
time to perform physical activity, the intensity level or 
duration, depending on working days or holidays. The 
MG Smartphone will allow configuring schedules and 
registering special events. As a result, the system will adapt 
reminders to reinforce compliance to physical activity. 
Also therapy related recommendations will be modified to 
consider parameters depending on the patient's personal 
context. Following the personalized parameters in Table 3, 
the system will not alert about practicing low intensity 
physical activity while the patient is in a work travel. When 
the patient is going to a dancing party, she is increasing her 
routine level of physical activity and she is eating not rec-
ommended nutrients. In this situation, the MG system 
will not insist on un-compliance but it will account for 
un-compliance events in case of repetitions. 
Table 3 Example: Preferred configuration of upcoming events 
Working Holidays Special event Special event 
days (e.g. dancing (e.g. work 
party) travel) 
#Required 4 2-3 Same as Same as 
daily BG holidays working days 
measurements 
^Required daily 1 0 1 3 
ketonuria levels 
Max. BG ranges 
(mg/dL) Same as Same as 
Preprandial <95 <105 holidays holidays 
Postprandial <130 < 145 
Preferred time to 18:30 11:00 - Afternoon 
perform physical 
activity 
Intensity level of Medium Medium High Low 
physical activity 
Physical activity 1 hour 30 min. 2 hours 1 hour 
duration 
Wake-up trmell II^ OZ-OO III[0:00 ^ ^^^IIIIZ^ZZIIII II01Í0 0IZ 
Preferred number 5 6 6 5 
of meals 
High sugar food -- - - Y e s Yes 
Reminders No Yes Yes Yes 
before BG 
measurements 
iv. CONCLUSIONS 
Gestational Diabetes local consensus guideline, which are 
parallel to recommendations for clinicians included in the 
CPG. The process has permitted to define the necessary 
steps to create a customized CIG that includes personaliza-
tion to each individual patient including specific preferences 
and context. The results will help to determine the level at 
which decisions should be placed in terms of MG DSS (at 
mobile-side DSS or backend server-side DSS). Those deci-
sions which could be taken by patients self-management 
will be part of the mobile DSS while decisions that need to 
be supported by clinicians will be placed in the server DSS. 
The distribution of DSS capabilities could be also modified 
depending on patients' customization or on the technologi-
cal context, such as the absence of connectivity. 
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This work presents three different types of advices (ther-
apy, measurements, upcoming events) extracted from the 
